1. Home
  2. GTH

GTH

Genetron Holdings Limited ADS

Logo Genetron Holdings Limited ADS

Health Care

Medical Specialities

Nasdaq

0

Genetron Holdings Ltd is an oncology company in China. It is specialized in cancer molecular profiling and harnesses advanced technologies in molecular biology and data science to transform cancer treatment. The company's operating segment includes Diagnosis and monitoring - provision for LDT services; Diagnosis and monitoring - sale of IVD products and Development services. It generates maximum revenue from the Diagnosis and monitoring - provision for LDT services segment.

Founded: 2015 Country:
China
China
Employees: N/A City: N/A
Market Cap: 127.1M IPO Year: 2020
Target Price: N/A AVG Volume (30 days): 51.7K
Analyst Decision: N/A Number of Analysts: N/A
Dividend Yield: N/A Dividend Payout Frequency: N/A
EPS: -3.61 EPS Growth: N/A
52 Week Low/High: $2.08 - $4.05 Next Earning Date: 04-09-2024
Revenue: $93,358,106 Revenue Growth: 25.37%
Revenue Growth (this year): 12.31% Revenue Growth (next year): 23.76%

Share on Social Networks: